Picture of Acumen Pharmaceuticals logo

ABOS — Acumen Pharmaceuticals News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Acumen Pharmaceuticals, Inc. Q3 Income From Operations USD -32.265 Million

Nov 12 (Reuters) - Acumen Pharmaceuticals, Inc. Q3 operating expenses USD
32.265 million.
* Q3 basic EPS USD -0.5
* Q3 net income USD -29.765 million

Recent news on Acumen Pharmaceuticals

See all news